# A Multi-centric Study to Assess the Efficacy of Sigmart in Subjects With Recurrent Angina After Coronary Revascularization

> **NCT01185015** · PHASE4 · WITHDRAWN · sponsor: **Merck KGaA, Darmstadt, Germany**

## Conditions studied

- Angina Pectoris

## Interventions

- **DRUG:** Sigmart (nicorandil)

## Key facts

- **NCT ID:** NCT01185015
- **Lead sponsor:** Merck KGaA, Darmstadt, Germany
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2011-01
- **Primary completion:** 2011-01
- **Final completion:** —
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2014-07-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01185015

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01185015, "A Multi-centric Study to Assess the Efficacy of Sigmart in Subjects With Recurrent Angina After Coronary Revascularization". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT01185015. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*